Association Between Dinutuximab Beta Exposure and Post-End-of-Treatment Survival in Neuroblastoma: A Weighted Patient-Level Analysis of Three Clinical Studies.

Pediatr Blood CancerJul 23, 2026 (epub)
Clinical ResearchOncology (Medical)

Przemysław Holko, Holger N Lode, Alberto Garaventa et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review analyzed the association between dinutuximab beta (DB) exposure and post-end-of-treatment survival in neuroblastoma patients using data from three clinical trials. Among 665 patients, increased cycles of DB treatment were linked to improved event-free survival (EFS) and overall survival (OS), with hazard ratios of 0.80 and 0.78 per cycle, respectively, both statistically significant (p < 0.001).

Key findings

  • Each additional cycle of DB treatment decreased the hazard of an EFS event by 20%.
  • Each additional cycle of DB treatment decreased the hazard of death by 22%.
  • In a target-trial emulation, 5 cycles of DB significantly improved EFS (HR = 0.46) and OS (HR = 0.44).
  • The median follow-up duration in the post-EOT cohort was 3.78 years.

Why it matters

Understanding the relationship between dinutuximab beta exposure and survival outcomes can guide clinicians in treatment planning and post-treatment risk assessment for neuroblastoma patients.

Source

PubMed · PMID 42487560

Published in Pediatr Blood Cancer. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.